Antigen presentation by endothelium: heparin reduces the immunogenicity of interferon-gamma-treated endothelial cells.
Douglas
M S
MS
Department of Surgery, University of Newcastle, Newcastle upon Tyne, UK.
Rix
D A
DA
Kirby
J A
JA
D000328:Adult; D000925:Anticoagulants / Q000494:pharmacology*; D017951:Antigen Presentation / Q000187:drug effects*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000276:immunology*; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006025:Glycosaminoglycans / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology*; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology
D000925:Anticoagulants; D006025:Glycosaminoglycans; D000949:Histocompatibility Antigens Class II; D007371:Interferon-gamma; D006493:Heparin